NEXGEL, Inc. (NXGL)
$4.05+6.30%Close
SELLCRISIS · day 41
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $37M
- Beta
- 0.81
- P/E (TTM)
- -0.01
- Short % float
- 4.56%
- Days to cover
- 1.0
- SI change
- +63.4%
- 1W
- +17.05%
- 1M
- -27.81%
- vs SPY 1W
- +17.19%
- vs SPY 1M
- -30.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 9
- GROWTH
- 16
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-79.9%
REV YoY-
ROE-133.1%
EPS YoY-
ROA-23.4%
GROSS35
OP-45
NET-51
[VALUATION]
P/E TTM-0.01
P/E FWD-
SECTOR PE20.34
INDUSTRY PE45.85
P/B0.02
P/FCF-
EV/EBITDA-3.34
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E150.70
ALTMAN Z-
CURR RATIO0.43
ND/EBITDA-
BETA0.81
Company news
FAQ
- What is LOPJLB’s current signal on NXGL?
- LOPJLB’s latest quantitative signal on NEXGEL, Inc. (NXGL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NXGL in?
- NEXGEL, Inc. (NXGL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does NEXGEL, Inc. (NXGL) do?
- NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery syst…